Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma.
Authors
Jakubowiak, Andrzej J.; Benson, Don M.; Bensinger, William; Siegel, David S. D.; Zimmerman, Todd M.; Mohrbacher, Ann; Richardson, Paul G.; Afar, Daniel E. H.; Singhal, Anil K.; Anderson, Kenneth C.
Publication
Journal of Clinical Oncology, 2012, Vol 30, Issue 16, p1960